source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[sampling time]	assay name	Technology Type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	characteristics[technical replicate]	comment[cleavage agent details]	comment[cleavage agent details].1	comment[MS2 mass analyzer]	comment[instrument]	comment[separation]	comment[modification parameters]	comment[modification parameters].1	comment[modification parameters].2	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150618_qep1_lc7_phge_sa_plate1b_44_2	proteomic profiling by mass spectrometry	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150618_qep1_lc7_phge_sa_plate1b_44_3	proteomic profiling by mass spectrometry	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150618_qep1_lc7_phge_sa_plate1b_44_4	proteomic profiling by mass spectrometry	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150618_qep1_lc7_phge_sa_plate1b_44_5	proteomic profiling by mass spectrometry	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150618_qep1_lc7_phge_sa_plate1b_44_6	proteomic profiling by mass spectrometry	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150618_qep1_lc7_phge_sa_plate1b_44_7	proteomic profiling by mass spectrometry	20150618_QEp1_LC7_PhGe_SA_Plate1B_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150618_QEp1_LC7_PhGe_SA_Plate1B_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150708_qep1_lc7_phge_sa_plate1c_44_3	proteomic profiling by mass spectrometry	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150708_qep1_lc7_phge_sa_plate1c_44_4	proteomic profiling by mass spectrometry	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150708_qep1_lc7_phge_sa_plate1c_44_5	proteomic profiling by mass spectrometry	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150708_qep1_lc7_phge_sa_plate1c_44_6	proteomic profiling by mass spectrometry	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150708_qep1_lc7_phge_sa_plate1c_44_7	proteomic profiling by mass spectrometry	20150708_QEp1_LC7_PhGe_SA_Plate1C_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150708_QEp1_LC7_PhGe_SA_Plate1C_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	11	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150805_qep1_lc7_phge_sa_plate1d_44_2	proteomic profiling by mass spectrometry	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	12	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150805_qep1_lc7_phge_sa_plate1d_44_3	proteomic profiling by mass spectrometry	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	13	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150805_qep1_lc7_phge_sa_plate1d_44_4	proteomic profiling by mass spectrometry	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	14	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150805_qep1_lc7_phge_sa_plate1d_44_5	proteomic profiling by mass spectrometry	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	15	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150805_qep1_lc7_phge_sa_plate1d_44_6	proteomic profiling by mass spectrometry	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	16	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150805_qep1_lc7_phge_sa_plate1d_44_7	proteomic profiling by mass spectrometry	20150805_QEp1_LC7_PhGe_SA_Plate1D_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150805_QEp1_LC7_PhGe_SA_Plate1D_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	17	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150901_qep1_lc7_phge_sa_plate1e_44_2	proteomic profiling by mass spectrometry	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	18	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	4W	20150901_qep1_lc7_phge_sa_plate1e_44_3	proteomic profiling by mass spectrometry	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_3.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	19	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	13W	20150901_qep1_lc7_phge_sa_plate1e_44_4	proteomic profiling by mass spectrometry	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_4.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	20	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	26W	20150901_qep1_lc7_phge_sa_plate1e_44_5	proteomic profiling by mass spectrometry	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_5.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	21	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	39W	20150901_qep1_lc7_phge_sa_plate1e_44_6	proteomic profiling by mass spectrometry	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_6.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	22	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	52W	20150901_qep1_lc7_phge_sa_plate1e_44_7	proteomic profiling by mass spectrometry	20150901_QEp1_LC7_PhGe_SA_Plate1E_44_7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150901_QEp1_LC7_PhGe_SA_Plate1E_44_7.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	23	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
PXD004242-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	not available	not available	not available	obesity	no depletion	0W	20150917_qep1_lc8_phge_sa_plate1c_44_2	proteomic profiling by mass spectrometry	20150917_QEp1_LC8_PhGe_SA_Plate1C_44_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2016/12/PXD004242/20150917_QEp1_LC8_PhGe_SA_Plate1C_44_2.raw	1	no fractionation	AC=MS:1002038;NT=label free sample	24	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309; CS='(?<=K)(?\!P)'	AC=MS:1000484; NT=Orbitrap	AC=MS:1002523; NT=Q Exactive HF	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	AC=MS:1000422;NT=HCD	27 NCE	7 ppm	20 ppm	blood plasma
